We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+16.28%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.15B
AUM Growth
-$662M
Cap. Flow
-$1.16B
Cap. Flow %
-28%
Top 10 Hldgs %
45.63%
Holding
100
New
26
Increased
16
Reduced
28
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 33.79%
2 Industrials 11.46%
3 Communication Services 10.72%
4 Consumer Discretionary 8.52%
5 Real Estate 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COO icon
51
Cooper Companies
COO
$14.2B
$12.3M 0.3%
378,168
-588
-0.2% -$19K
HUM icon
52
Humana
HUM
$43.9B
$11.7M 0.28%
+124,821
New +$11.5M
EPZM
53
DELISTED
Epizyme, Inc
EPZM
$11.2M 0.27%
281,136
-127,472
-31% -$4.32M
AGN
54
DELISTED
Allergan plc
AGN
$9.6M 0.23%
66,659
-692,554
-91% -$92.3M
CFN
55
DELISTED
CAREFUSION CORPORATION
CFN
$9.11M 0.22%
246,921
-74,091
-23% -$2.77M
RAD
56
DELISTED
Rite Aid Corporation
RAD
$8.97M 0.22%
94,244
+43,204
+85% +$2.95M
GPOR
57
DELISTED
Gulfport Energy Corp.
GPOR
$8.96M 0.22%
+139,329
New +$7.79M
MOH icon
58
Molina Healthcare
MOH
$10.4B
$8.94M 0.22%
250,989
-61,514
-20% -$2.27M
VTRS icon
59
Viatris
VTRS
$20.8B
$8.93M 0.22%
+233,887
New +$8.23M
GNMK
60
DELISTED
GenMark Diagnostics, Inc
GNMK
$7.89M 0.19%
650,015
+45,816
+8% +$491K
BHC icon
61
Bausch Health
BHC
$1.75B
$6.5M 0.16%
62,308
-226,769
-78% -$22.1M
AGIO icon
62
Agios Pharmaceuticals
AGIO
$2.08B
$5.78M 0.14%
+206,829
New +$5.71M
BLUE
63
DELISTED
bluebird bio
BLUE
$5.33M 0.13%
+15,278
New +$5.67M
SIRO
64
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$4.73M 0.11%
70,697
-904,203
-93% -$61M
WAT icon
65
Waters Corp
WAT
$37.3B
$4.57M 0.11%
43,054
+1,199
+3% +$123K
MYGN icon
66
Myriad Genetics
MYGN
$476M
$3.46M 0.08%
+147,376
New +$4.19M
WAT icon
67
CALL
Waters Corp
WAT
$37.3B
$470K 0.01%
+329,600
New +$33.8M
RPRX
68
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$127K ﹤0.01%
+168,800
New +$3.62M
MRK icon
69
CALL
Merck
MRK
$322B
$101K ﹤0.01%
480,718
-150,283
-24% -$6.86M
MYGN icon
70
CALL
Myriad Genetics
MYGN
$476M
$87K ﹤0.01%
+194,000
New +$5.51M
ALGN icon
71
Align Technology
ALGN
$12.9B
-380,020
Closed -$14.1M
AMCX icon
72
AMC Global Media
AMCX
$450M
-889,813
Closed -$58.1M
BB icon
73
BlackBerry
BB
$4.58B
-392,958
Closed -$4.11M
BIIB icon
74
Biogen
BIIB
$30.9B
-96,017
Closed -$20.7M
BWA icon
75
BorgWarner
BWA
$12.8B
-2,095,377
Closed -$79.5M

Similar funds

PFM Health Sciences's Q3 2013 Portfolio in Review

As of Q3 2013, PFM Health Sciences held 100 positions worth $4.15B, down 14% from $4.81B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

PFM Health Sciences withdrew a net $1.16B in Q3 2013, closing 28 positions and reducing 28 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $252M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Adobe worth $106M.

  • PFM Health Sciences's largest Q3 2013 buy was Adobe: 2,042,347 shares worth $106M.
  • PFM Health Sciences added most to CAMERON INTERNATIONAL CORPORATION in Q3 2013, an estimated $79.6M increase.
  • PFM Health Sciences's biggest Q3 2013 reduction was Pfizer, cutting an estimated $205M.
  • PFM Health Sciences fully exited Alphabet (Google) Class C in Q3 2013, selling an estimated $252M.
  • PFM Health Sciences's ten largest holdings make up 46% of its $4.15B portfolio in Q3 2013.
  • PFM Health Sciences opened 26 new positions and closed 28 in Q3 2013.
  • PFM Health Sciences's portfolio value fell 14% quarter-over-quarter to $4.15B.

Based on PFM Health Sciences's 13F filing for Q3 2013, filed 14 Nov 2013.